TyraTech
<< < > >>
Search:
 
| Full PDF report | Print this page |
Annual Report & Accounts 2014 - Director's Report
slide
<< < > >>
TYRATECH • ANNUAL REPORT 2014 • PAGE 12 D i r e c t o r 's Rep o r t ( c o n t ' d ) following American Vanguard's acquisition of GemChem, a national and international chemical distribution company he cofounded in 1991. From 1977 to 1982, he worked for AMVAC in a variety of sales, purchasing, and production control capacities. Previously, as a Vice President and Director of R.W. Greeff & Co. from 1982 to 1991, Mr. Wintemute oversaw the national and international distribution of key AMVAC chemical products. Mr. Wintemute holds a Bachelor of Science degree from the University of California, San Diego. DIRECTORS' INTERESTS The Directors had beneficial interests in the share capital of the Company, other than with respect to options to acquire ordinary shares (which are detailed in the analysis of options included in the Directors' Remuneration Report) as follows: 1 June, 2015 1 January, 2014 (or earlier date (or later date of resignation) of appointment) Common Shares Common Shares of $0.001 each of $0.001 each A.J. Reade 12,733,616 10,486,358 B.M. Riley 3,198,413 2,455,556 J. Hills 1,240,757 565,500 E. Wintemute – – B. Jactel 2,002,424 1,365,204 DIRECTORS INDEMNITY INSURANCE The Company has taken out insurance to indemnify, against third party proceedings, the Directors of the Company whilst serving on the Board of the Company and of any subsidiary, associate or joint venture. This cover indemnifies all employees of the Company who serve on the boards of all subsidiaries. These qualifying third party indemnity policies subsisted throughout the year and remain in place at the date of this report. CAPITAL STRUCTURE The capital structure of the Company comprises common shares of $0.001 par value each. Common shares in the capital of the Company are not registered under the US Securities Act of 1933 (Securities Act), as amended, the US Securities Exchange Act of 1934, as amended, or under any US state securities laws. As such, on issue common shares are "restricted securities" as defined in Rule 144 under the Securities Act and may not be resold in the United States absent registration under the Securities Act and any applicable securities laws of any U.S. State or pursuant to exemptions under the Securities Act and such laws. On issue common shares will be in certificated form with an appropriate form of restrictive legend and subject, in the case of shares subscribed and held by nonaffiliates of the Company to a one year distribution compliance period under Regulation S under the Securities Act. During the distribution compliance period such common shares may only be traded through the delivery of physical certificates outside of the United States in offshore transactions to non-US Persons and otherwise in compliance with the Securities Act and any applicable securities laws of any state of the United States. Common shares subscribed and held by non-affiliates of the Company will be eligible to have the restrictive legend removed from their certificates representing such shares following the first anniversary of the issue of such shares and, on completion of an appropriate letter of transmittal available from the Company for migration of such shares to the Company's unrestricted line of stock. A depositary interest facility is available that permits trades in shares in the Company's unrestricted line of stock to be settled electronically through CREST rather than by delivery of physical certificates. American Vanguard Corporation, a substantial shareholder of the Company, entered into a Relationship Agreement with the Company on 18 March 2013 pursuant to which it is subject to a 2-year orderly market lock-up period (following the expiry of a 180 day lock-up period which commenced on the date of the agreement and which has now expired). During the orderly market lock-up period American Vanguard Corporation and its associates are prohibited from transferring or otherwise disposing of any securities in the Company other than to an associate of American Vanguard Corporation to the extent permitted under the Relationship Agreement or through a sale brokered by the Company's nominated adviser in order to maintain an orderly market in the common shares.